 |
|
|
|
|
|
|
|
Management Team
 |
|
Ichiro (Paul) Mori
Executive Vice President and COO
|
Paul Mori has served as the executive vice president of Teikoku Pharma USA (TPU) since co-founding the company in June 1997. Mr. Mori brings over 23 years of international pharmaceutical business experience. While at TPU, he has established relationships with major US companies -- among them Becton Dickinson and Bristol-Myers Squibb. Prior to joining TPU, he held a position as international operations manager for 12 years with Green Cross Corporation (now Mistubishi Pharma) in Osaka, Japan. There, he was involved in Fluosol and Soyacal NDA approvals. He was then transferred to Alpha Therapeutic Corporation in Los Angeles, California where he worked as assistant director of International Regulatory Affairs for 4 years. While at Alpha he was involved in various product registrations of pharmaceutical/biological products in over 20 countries. He received his bachelor's degree from Kobe University in 1981.
|
|
|
|
|
|
 |
Copyright © 2006 Teikoku Pharma USA, Inc. All Rights Reserved.
Teikoku Pharma USA, Teikoku, Teikoku Pharma, Teikoku Seiyaku Co., drug delivery systems, TDS, patches, unit-dose jellies, unit-dose liquids, creams and ointments, delivery products, pain management, cosmetic care, TDS technologies, patent protections, prescription, otcs, medical device market, applications, transdermal drug delivery technologies, Lidoderm, Endo Pharmaceuticals, post-herpetic neuralgia, TDS-based health and beauty products, face masks, anti-wrinkle patches, skin whiteners, and cuticle softe
|
|
